MaxCyte, Inc. Files Q1 2025 10-Q
Ticker: MXCT · Form: 10-Q · Filed: May 8, 2025 · CIK: 1287098
| Field | Detail |
|---|---|
| Company | Maxcyte, INC. (MXCT) |
| Form Type | 10-Q |
| Filed Date | May 8, 2025 |
| Risk Level | low |
| Sentiment | neutral |
Sentiment: neutral
Topics: 10-Q, financials, research
TL;DR
MaxCyte's Q1 2025 10-Q is in. Check financials.
AI Summary
MaxCyte, Inc. filed its 10-Q for the period ending March 31, 2025. The filing details financial information, including common stock and retained earnings as of March 31, 2025, and comparative periods. The company is involved in commercial physical & biological research.
Why It Matters
This filing provides investors with the latest financial snapshot of MaxCyte, Inc., crucial for understanding its performance and financial health in early 2025.
Risk Assessment
Risk Level: low — This is a standard quarterly financial filing with no immediate red flags or significant new disclosures.
Key Numbers
- 20250331 — Reporting Period End Date (Indicates the end of the financial quarter being reported.)
- 20250508 — Filing Date (Shows when the report was officially submitted to the SEC.)
Key Players & Entities
- MAXCYTE, INC. (company) — Filer of the 10-Q
- 20250331 (date) — End of the reporting period
- 20250508 (date) — Filing date
- 8731 (number) — Standard Industrial Classification code for Services-Commercial Physical & Biological Research
FAQ
What is the primary business of MaxCyte, Inc. according to the filing?
MaxCyte, Inc. is classified under Standard Industrial Classification code 8731, which pertains to Services-Commercial Physical & Biological Research.
What is the reporting period for this 10-Q filing?
The Conformed Period of Report is March 31, 2025.
When was this 10-Q filed with the SEC?
The filing date (FILED AS OF DATE) is May 8, 2025.
What financial elements are specifically mentioned with dates in the filing data?
The filing data mentions Common Stock, Restricted Stock Units (RSUs), Over-Allotment Options, Retained Earnings, and Additional Paid-In Capital with specific dates related to reporting periods (e.g., 2025-01-01 to 2025-03-31, 2025-03-31, 2024-12-31).
What is the SEC file number for MaxCyte, Inc.?
The SEC File Number is 001-40674.
Filing Details
This Form 10-Q (Form 10-Q) was filed with the SEC on May 8, 2025 regarding MAXCYTE, INC. (MXCT).